US · FLGC
Flora Growth Corp.
- Sector
- Healthcare · Drug Manufacturers - Specialty & Generic
- Headquarters
- Toronto, ON M5H 2V1
- Website
- floragrowth.com
Price · as of 2024-12-31
—
Market cap 5.5M
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $58.23 | — |
| Intrinsic Value(DCF) | $10.18 | — |
| Graham-Dodd Method(GD) | — | — |
| Graham Formula(GF) | $16.50 | — |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2010 | |||||
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | |||||
| 2015 | |||||
| 2016 | |||||
| 2017 | |||||
| 2018 | |||||
| 2019 | |||||
| 2020 | |||||
| 2021 | $1,318.20 | $1,568.26 | $0.00 | $0.00 | $0.00 |
| 2022 | $273.16 | $167.84 | $0.72 | $0.00 | $0.00 |
| 2023 | $42.51 | $82.42 | $549,904.83 | $0.00 | $0.00 |
| 2024 | $25.44 | $58.23 | $86.81 | $0.00 | $16.50 |
AI valuation
Our deep-learning model estimates Flora Growth Corp.'s (FLGC) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $58.23
- Current price
- —
- AI upside
- —
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$10.18
— upside
Graham-Dodd
—
— upside
Graham Formula
$16.50
— upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| FLGC | Flora Growth Corp. | $9.50 | 5.5M | +513% | +7% | — | +74% | -19.62 | 69.19 | 5.24 | -20.59 | — | -1289.54 | 21.00% | -26.73% | -26.73% | -291.50% | -345.04% | -63.82% | 1.09 | -74.68 | 1.05 | 0.71 | 0.07 | -8226.00% | -2178.00% | -3964.00% | -1.66% | -0.27 | -113.30% | 0.00% | 0.00% | 0.14% | -19.55 | -60.19 | 5.23 | 0.49 |
| AKAN | Akanda Corp. | $1.40 | 3.19M | +7,040% | +614% | — | +14,054% | -6.36 | 6.09 | 31.14 | -7.45 | — | 6.11 | 24.91% | -523.80% | -489.57% | -1830.03% | -998.53% | -48.90% | 0.08 | -43.78 | 1.39 | 1.28 | 1.15 | -9355.00% | -6127.00% | 30467.00% | -23.33% | -1.09 | -1384.96% | 0.00% | 0.00% | 28.41% | -5.15 | -3.71 | 26.97 | -7.37 |
| AMIX | Autonomix Medical, Inc. C… | $0.84 | 4.3M | — | — | — | — | -0.23 | 0.32 | — | 0.59 | — | 0.32 | 0.00% | — | — | -145.10% | 2283.35% | -118.77% | 0.00 | -65.84 | 5.63 | 5.35 | 0.83 | -6937.00% | — | 2407.00% | -316.49% | -4.84 | 1629.95% | 0.00% | 0.00% | 58.54% | 0.56 | 0.79 | — | -9.21 |
| ENSC | Ensysce Biosciences, Inc. | $2.08 | 4.93M | +770,652,285% | -3% | — | — | -1.10 | 2.36 | 1.68 | -0.83 | — | 2.36 | -38.57% | -129.17% | -153.30% | -471.83% | 16069.72% | -192.33% | 0.08 | -5.22 | 2.42 | 1.64 | 0.48 | -256.00% | 13353.00% | 6959834645.00% | -85550186.53% | -3399198.17 | 17914756446.99% | 3306.75% | -3630.90% | 3340.18% | -0.83 | 0.00 | 1.07 | -32.39 |
| KALA | KALA BIO, Inc. | $0.76 | 5.35M | — | — | — | — | -1.01 | 3.16 | — | -0.49 | — | 3.16 | 0.00% | — | — | -388.29% | 599.82% | -69.12% | 2.62 | -7.09 | 3.11 | 3.02 | 0.46 | -5977.00% | — | 369.00% | -76.03% | -1.73 | 433.08% | 0.00% | 0.00% | 11.20% | -0.49 | -0.68 | — | -17.97 |
| KZIA | Kazia Therapeutics Limite… | $7.68 | 4.42M | +110% | -60% | — | +13,728% | -0.63 | -1.56 | 309.03 | -0.68 | — | -1.38 | 100.00% | -33850.00% | -49290.48% | 226.03% | 112.59% | -149.76% | -0.05 | — | 0.35 | 0.32 | 0.30 | -6564.00% | -9818.00% | 3859.00% | -102.30% | -0.94 | 114.02% | 0.00% | 0.00% | 22.54% | -0.64 | -0.68 | 215.01 | -40.14 |
| MYNZ | Mainz Biomed B.V. | $1.42 | 5.81M | +15,965% | +58% | — | — | -0.25 | 0.90 | 6.08 | -0.13 | -0.02 | 1.79 | 64.31% | -2091.23% | -2421.80% | -465.82% | -559.63% | -151.15% | 0.54 | -17.39 | 1.32 | 1.08 | 0.15 | 128025.00% | -17.00% | -2724.00% | -319.32% | -2.87 | -519.21% | 0.00% | 0.00% | 61.01% | -0.13 | -0.14 | 2.76 | -13.59 |
| RDHL | RedHill Biopharma Ltd. | $1.11 | 3.7M | +35,030% | +14% | — | — | -0.94 | -1.66 | 0.97 | -0.46 | — | -0.76 | 60.31% | -181.69% | -102.80% | 632.60% | 242.32% | -40.24% | -0.08 | -265.69 | 0.54 | 0.37 | 0.56 | -11522.00% | 2317.00% | -7383.00% | -120.72% | -0.42 | 155.51% | 0.00% | 0.00% | 0.00% | -0.24 | -0.37 | 0.44 | -34.89 |
About Flora Growth Corp.
Flora Growth Corp., together with its subsidiaries, engages in the growth, cultivation, and development of medicinal cannabis and medicinal cannabis derivative products to pharmacies, medical clinics, and cosmetic companies worldwide. It cultivates, processes, and supplies medicinal-grade cannabis oil, and cannabis derived medical and wellness products; offers skincare and beauty products; develops plant-based and medical-grade pharmaceuticals, phytotherapeutics, and dietary supplements; and designs and markets loungewear made from hemp-derived fabric and materials. The company also manufactures, distributes, and retails cannabidiol (CBD) derived products, such as gummies, topicals, tinctures, and vape products; lifestyle wellness products, including edibles, bath and body, pets, sports recovery, etc.; provides cannabis consumption accessories, personal storage, and travel accessories for vape and dry herb categories; and offers juices, exotic fruits coated with chocolate, and chocolate bars, as well as dried fruits, beans, and pulp from Amazonian fruits in supermarkets, discount retailers, coffee shops, restaurants, and airports. In addition, it engages in the manufacturing, promotion, and distribution of beverage products; manufacture and sale of product formulations for pain relief; and development of pharmaceutical cannabinoid formula for the prevention of Sars-Cov-2. The company sells its products under the JustCBD, Vessel, Mind Naturals, Mambe, Stardog, Tonino Lamborghini, and Kalaya brands. Flora Growth Corp. was incorporated in 2019 and is headquartered in Toronto, Canada.
- CEO
- Clifford A. Starke
- Employees
- 64
- Beta
- 1.87
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($10.18 ÷ —) − 1 = — (DCF, example).